Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (otvorí nové okno)

Abdelrazik N, Fouda M

Zdroj‎: Hematology 2007;12(6):533-41.

Označenie‎: PubMed 17852440

Identifikátor digitálneho objektu‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (otvorí nové okno)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (otvorí nové okno)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Zdroj‎: Cancer 2012;118(3):848-55.

Označenie‎: PubMed 21751205

Identifikátor digitálneho objektu‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (otvorí nové okno)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (otvorí nové okno)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Zdroj‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Označenie‎: PubMed 18728970

Identifikátor digitálneho objektu‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (otvorí nové okno)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (otvorí nové okno)

Durmaz O, Demirkaya M, Sevinir B

Zdroj‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Označenie‎: PubMed 21707225

Identifikátor digitálneho objektu‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (otvorí nové okno)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (otvorí nové okno)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Zdroj‎: J Clin Oncol 2010;28(13):2239-45.

Označenie‎: PubMed 20368566

Identifikátor digitálneho objektu‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (otvorí nové okno)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (otvorí nové okno)

Hassan BA, Yusoff ZB

Zdroj‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Označenie‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (otvorí nové okno)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (otvorí nové okno)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Zdroj‎: Curr Med Res Opin 2009;25(9):2109-20.

Označenie‎: PubMed 19601709

Identifikátor digitálneho objektu‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (otvorí nové okno)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (otvorí nové okno)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Zdroj‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Označenie‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (otvorí nové okno)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (otvorí nové okno)

Hiradfar A, Banihosseinian M

Zdroj‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Označenie‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (otvorí nové okno)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (otvorí nové okno)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Zdroj‎: Pediatr Blood Cancer 2009;53(1):7-12.

Označenie‎: PubMed 19229970

Identifikátor digitálneho objektu‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (otvorí nové okno)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (otvorí nové okno)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Zdroj‎: Cancer 2013;119(1):107-14.

Označenie‎: PubMed 22744794

Identifikátor digitálneho objektu‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (otvorí nové okno)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (otvorí nové okno)

Mystakidou K, Potamianou A, Tsilika E

Zdroj‎: Curr Med Res Opin 2007;23(11):2841-7.

Označenie‎: PubMed 17910805

Identifikátor digitálneho objektu‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (otvorí nové okno)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (otvorí nové okno)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Zdroj‎: J Clin Oncol 2006;24(22):3583-9.

Označenie‎: PubMed 16877725

Identifikátor digitálneho objektu‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (otvorí nové okno)

The role of recombinant erythropoietin in childhood cancer. (otvorí nové okno)

Shankar AG

Zdroj‎: Oncologist 2008;13(2):157-66.

Označenie‎: PubMed 18305061

Identifikátor digitálneho objektu‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (otvorí nové okno)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (otvorí nové okno)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Zdroj‎: MEDICC Rev 2010;12(3):27-31.

Označenie‎: PubMed 20697335

Identifikátor digitálneho objektu‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (otvorí nové okno)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (otvorí nové okno)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Zdroj‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Označenie‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (otvorí nové okno)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (otvorí nové okno)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Zdroj‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Označenie‎: PubMed 24088186

Identifikátor digitálneho objektu‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (otvorí nové okno)

Early epoetin alfa treatment in children with solid tumors. (otvorí nové okno)

Zoubek A, Kronberger M

Zdroj‎: Med Pediatr Oncol 2002;39(4):459-62.

Označenie‎: PubMed 12203664

Identifikátor digitálneho objektu‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (otvorí nové okno)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (otvorí nové okno)

Crary SE, Hall K, Buchanan GR.

Zdroj‎: Pediatr Blood Cancer 2011;56(4):615-9.

Označenie‎: PubMed 21298748

Identifikátor digitálneho objektu‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (otvorí nové okno)

Intravenous iron sucrose for children with iron deficiency anemia. (otvorí nové okno)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Zdroj‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Označenie‎: PubMed 28562517

Identifikátor digitálneho objektu‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (otvorí nové okno)

Advances in Pediatric Intravenous Iron Therapy. (otvorí nové okno)

Mantadakis E.

Zdroj‎: Pediatr Blood Cancer 2016;63(1):11-6.

Označenie‎: PubMed 26376214

Identifikátor digitálneho objektu‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (otvorí nové okno)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (otvorí nové okno)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Zdroj‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Označenie‎: PubMed 26845108

Identifikátor digitálneho objektu‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (otvorí nové okno)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (otvorí nové okno)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Zdroj‎: J Clin Oncol 2008;26(10):1619-25.

Označenie‎: PubMed 18375891

Identifikátor digitálneho objektu‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (otvorí nové okno)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (otvorí nové okno)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Zdroj‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Označenie‎: PubMed 23832487

Identifikátor digitálneho objektu‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (otvorí nové okno)